DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility
Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not wel...
Saved in:
Published in | Arthritis & rheumatology (Hoboken, N.J.) Vol. 64; no. 7; pp. 2338 - 2345 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2012
Wiley Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up‐regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.
Methods
CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real‐time reverse transcription–polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.
Results
CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.
Conclusion
Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. |
---|---|
AbstractList | Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. [PUBLICATION ABSTRACT] Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.OBJECTIVESystemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.METHODSCD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.RESULTSCD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.CONCLUSIONDemethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up‐regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real‐time reverse transcription–polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. |
Author | Lu, QianJin Lian, XiaoRi Wang, YaoYao Zhao, Ming Hu, Xinhong Yang, Yan Jiang, HongYan Xiao, Rong Li, YaPing Kanekura, Takuro |
Author_xml | – sequence: 1 givenname: XiaoRi surname: Lian fullname: Lian, XiaoRi organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 2 givenname: Rong surname: Xiao fullname: Xiao, Rong email: xiaorong65@yahoo.com.cn organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 3 givenname: Xinhong surname: Hu fullname: Hu, Xinhong organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 4 givenname: Takuro surname: Kanekura fullname: Kanekura, Takuro organization: Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 5 givenname: HongYan surname: Jiang fullname: Jiang, HongYan organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 6 givenname: YaPing surname: Li fullname: Li, YaPing organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 7 givenname: YaoYao surname: Wang fullname: Wang, YaoYao organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 8 givenname: Yan surname: Yang fullname: Yang, Yan organization: Second Xiangya Hospital and Central South University, Changsha, China – sequence: 9 givenname: Ming surname: Zhao fullname: Zhao, Ming organization: Second Xiangya Hospital, Central South University, and Hunan Key Laboratory of Medical Epigenomics, Changsha, China – sequence: 10 givenname: QianJin surname: Lu fullname: Lu, QianJin organization: Second Xiangya Hospital and Central South University, Changsha, China |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26177047$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22231486$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1rFDEUhoNU7LZ64R-QgAgWmTZfM9np3TLVKi4VZLXiTcjMntDUzGRNZtnOVf-62S-FoniV5PC8L-ecvEfooPMdIPScklNKCDvToT_lgsviERrRnJUZoZweoBEhRGQ8L-khOorxNj0Zz_kTdMgY41SMixG6v7ia4Dm00N8MTvfWd9gbXF0IMsW2W1_e4BluwLmITfAtXvkWOryy_Q2OQ-yhtQ2OjYPgo43neIIXPkZbO8Bwt3C623oaH7CBVqdyXMYGFr2trbP98BQ9NtpFeLY7j9GXd29n1fts-unyQzWZZo3IRZHNpeCsrkWdl4bMoebjojam5loWOTBm8oLTeakZ0VKKUmsKvCjTsEBoAyUv-TF6vfVdBP9zCbFXrY3rsXQHfhkVzbkYc8mJ-D9KGBvzclyShL58gN76ZejSIMmQSkpTNzJRL3bUsm5hrhbBtjoMav8LCXi1A3RstDNBd42Nf7gi-ZCN0dmWa9K2YwCjGttvFtwHbV3qTK3zoFIe1CYPSXHyQLE3_Ru7c19ZB8O_QTX5PNsrsq3CpiDc_Vbo8EMVkstcXV9dqq_X7Pu3j5VQFf8FijvRKQ |
CODEN | ARHEAW |
CitedBy_id | crossref_primary_10_1038_s41584_020_0470_9 crossref_primary_10_1038_nrd_2016_185 crossref_primary_10_1186_s13148_023_01445_5 crossref_primary_10_1016_j_jaut_2017_05_004 crossref_primary_10_1186_1868_7083_6_25 crossref_primary_10_1038_s41392_024_01929_7 crossref_primary_10_1053_j_seminhematol_2013_03_022 crossref_primary_10_1038_nrrheum_2017_220 crossref_primary_10_1016_j_tig_2020_06_016 crossref_primary_10_1111_1756_185X_13175 crossref_primary_10_3389_fimmu_2018_03112 crossref_primary_10_1016_j_jbspin_2014_03_004 crossref_primary_10_1016_j_jaut_2014_05_001 crossref_primary_10_1007_s00281_015_0507_3 crossref_primary_10_1007_s12016_013_8392_9 crossref_primary_10_1177_0961203320965690 crossref_primary_10_1093_rheumatology_keu155 crossref_primary_10_1016_j_jaut_2016_02_011 crossref_primary_10_1038_nrrheum_2014_128 crossref_primary_10_1016_j_clim_2012_07_006 crossref_primary_10_1016_j_biocel_2015_06_004 crossref_primary_10_2217_ijr_13_20 crossref_primary_10_1111_exd_14986 crossref_primary_10_23868_gc120579 crossref_primary_10_1016_j_healun_2016_02_007 crossref_primary_10_1155_2018_7342472 crossref_primary_10_1016_j_trsl_2018_08_001 crossref_primary_10_1177_1759720X20918456 crossref_primary_10_1016_j_heliyon_2024_e32366 crossref_primary_10_1038_gene_2014_44 crossref_primary_10_1016_j_clim_2015_03_006 crossref_primary_10_3390_biomedicines10123030 crossref_primary_10_1111_exd_12673 crossref_primary_10_1186_s13075_022_02741_w crossref_primary_10_3389_fimmu_2019_02305 crossref_primary_10_1007_s11926_017_0685_1 crossref_primary_10_1016_j_berh_2017_09_006 crossref_primary_10_1016_j_autrev_2015_05_008 crossref_primary_10_1007_s00281_015_0504_6 crossref_primary_10_1126_sciadv_adn6537 crossref_primary_10_1159_000457944 crossref_primary_10_1007_s11926_019_0877_y crossref_primary_10_5301_jsrd_5000209 crossref_primary_10_2147_IJGM_S356877 crossref_primary_10_1002_wrna_70003 crossref_primary_10_1111_sji_12121 crossref_primary_10_1016_j_clim_2018_03_011 crossref_primary_10_1136_annrheumdis_2011_201246 crossref_primary_10_7759_cureus_35593 crossref_primary_10_1084_jem_20211487 crossref_primary_10_3109_08916934_2015_1134511 crossref_primary_10_3389_fimmu_2018_02998 crossref_primary_10_1177_2397198319855872 crossref_primary_10_1155_2020_4286047 crossref_primary_10_1586_1744666X_2015_994507 crossref_primary_10_1016_j_autrev_2016_01_016 crossref_primary_10_1016_j_biocel_2015_05_023 crossref_primary_10_1007_s12016_016_8534_y crossref_primary_10_1007_s10067_020_05255_5 crossref_primary_10_1038_nrrheum_2017_147 crossref_primary_10_3389_fimmu_2022_921765 crossref_primary_10_1016_j_clim_2012_01_017 crossref_primary_10_1016_j_rhum_2014_03_001 crossref_primary_10_1111_apt_14324 crossref_primary_10_1111_eci_12899 crossref_primary_10_1038_s41584_021_00683_2 crossref_primary_10_1111_exd_12767 crossref_primary_10_3390_cells12192376 crossref_primary_10_2217_epi_2016_0096 crossref_primary_10_1136_annrheumdis_2012_202742 crossref_primary_10_1186_s13073_020_00779_6 crossref_primary_10_1007_s12016_022_08956_8 crossref_primary_10_1016_j_mam_2016_10_001 crossref_primary_10_1080_09546634_2018_1473550 crossref_primary_10_1177_2397198318758221 crossref_primary_10_1016_j_clim_2013_06_006 crossref_primary_10_1007_s10238_019_00568_5 crossref_primary_10_1111_1346_8138_13185 crossref_primary_10_1016_j_autrev_2018_11_001 crossref_primary_10_1007_s10620_018_5072_x crossref_primary_10_1007_s12016_024_09003_4 crossref_primary_10_1016_j_jaut_2016_06_020 crossref_primary_10_1007_s00296_023_05446_8 crossref_primary_10_3389_fgene_2015_00022 crossref_primary_10_3389_fimmu_2018_00478 crossref_primary_10_1016_j_biopha_2016_12_072 crossref_primary_10_3389_fgene_2014_00438 crossref_primary_10_1016_j_jaut_2013_01_010 crossref_primary_10_1186_s13148_019_0632_2 crossref_primary_10_1016_j_jaut_2013_01_012 crossref_primary_10_1038_nrrheum_2014_218 crossref_primary_10_3390_diagnostics14060652 crossref_primary_10_1111_bph_14783 crossref_primary_10_1111_exd_12900 crossref_primary_10_1007_s00281_017_0621_5 crossref_primary_10_1038_s41577_024_00996_9 crossref_primary_10_3389_fimmu_2023_1298665 crossref_primary_10_1111_1346_8138_13221 crossref_primary_10_1016_j_humimm_2018_01_003 |
Cites_doi | 10.1038/ni0901-777 10.1093/jn/132.8.2401S 10.1002/eji.200324088 10.4049/jimmunol.174.10.6212 10.1016/j.jaut.2009.03.007 10.1016/j.autrev.2011.04.013 10.4049/jimmunol.168.7.3649 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F 10.1136/ard.2007.073387 10.1002/art.23994 10.4049/jimmunol.172.6.3652 10.2741/1842 10.1080/03009740902758875 10.1016/j.jaut.2009.12.006 10.1002/art.10234 10.1038/sj.onc.1205609 10.1126/science.1136352 10.3109/08820130009062292 10.1016/j.semarthrit.2007.10.010 10.4049/jimmunol.179.9.6352 10.1016/j.it.2011.02.004 10.1080/08916930400002386 10.1016/j.autrev.2011.04.016 10.1007/s00018-003-3121-9 10.1146/annurev.iy.12.040194.004313 10.1006/jaut.2000.0387 10.1038/190372a0 10.1385/IR:27:2-3:185 |
ContentType | Journal Article |
Copyright | Copyright © 2012 by the American College of Rheumatology 2015 INIST-CNRS Copyright © 2012 by the American College of Rheumatology. |
Copyright_xml | – notice: Copyright © 2012 by the American College of Rheumatology – notice: 2015 INIST-CNRS – notice: Copyright © 2012 by the American College of Rheumatology. |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7QP 7T5 7TM 7U7 C1K H94 K9. 7X8 |
DOI | 10.1002/art.34376 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Toxicology Abstracts Nucleic Acids Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1529-0131 2326-5205 |
EndPage | 2345 |
ExternalDocumentID | 3277941551 22231486 26177047 10_1002_art_34376 ART34376 ark_67375_WNG_VW2ZXKC4_C |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministry of Science and Technology of the People's Republic of China funderid: International S&T Cooperation Project 2008DFA31980 – fundername: National Natural Science Foundation of China funderid: 30972662 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 10A 1CY 1KJ 1L6 1OB 1OC 1ZS 23N 24P 31~ 33P 3O- 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5RE 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAKAS AANLZ AAQQT AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACMXC ACPOU ACSCC ACXBN ACXQS ADBTR ADEOM ADIZJ ADMGS ADOZA ADZCM ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AI. AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZFZN BDRZF BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J5H JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M65 MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NNB OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q11 QB0 QRW RGB RIWAO RJQFR ROL RWI RX1 RXW RYL SAMSI SJN SUPJJ SV3 TAE TEORI TWZ UB1 V2E V8K V9Y VH1 W8V WH7 WIB WIH WIJ WIK WIN WJL WOW WQJ WRC WUP WXI WXSBR X6Y X7M XG1 XPP XV2 YFH YOC ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ AAFWJ AAYXX AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 0R~ 3SF 52U 52V 5VS 7QL 7QP 7T5 7TM 7U7 AAESR AASGY ABLJU ABPVW ACGFS ACGOF ACIWK ACPRK ADBBV ADKYN ADXAS ADZMN AENEX AEYWJ AFRAH AHMBA ALAGY ALVPJ AZVAB BFHJK BHBCM BMXJE C1K DIK FUBAC H94 K9. KBYEO NF~ O66 O9- PQQKQ WBKPD WHWMO WOHZO WVDHM 7X8 |
ID | FETCH-LOGICAL-c4546-d7432bb4b59f0deb386bffb3a765e22f5631d9a20a7749aa1e369235e01ce9393 |
IEDL.DBID | DR2 |
ISSN | 0004-3591 2326-5191 1529-0131 |
IngestDate | Fri Jul 11 08:52:37 EDT 2025 Thu Jul 10 23:58:03 EDT 2025 Mon Jun 30 10:15:58 EDT 2025 Thu Apr 03 07:01:51 EDT 2025 Mon Jul 21 09:15:39 EDT 2025 Tue Jul 01 01:05:19 EDT 2025 Thu Apr 24 22:53:55 EDT 2025 Wed Jan 22 16:29:43 EST 2025 Wed Oct 30 09:51:35 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Immunopathology Connective tissue disease Skin disease Rheumatology Autoimmune disease Immunological investigation DNA Systemic disease T-Lymphocyte Female Woman Scleroderma |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 Copyright © 2012 by the American College of Rheumatology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4546-d7432bb4b59f0deb386bffb3a765e22f5631d9a20a7749aa1e369235e01ce9393 |
Notes | ArticleID:ART34376 istex:8E3E5CBB3811653E028167D1F476974796BF1230 Ministry of Science and Technology of the People's Republic of China - No. International S&T Cooperation Project 2008DFA31980 ark:/67375/WNG-VW2ZXKC4-C National Natural Science Foundation of China - No. 30972662 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 22231486 |
PQID | 1517117747 |
PQPubID | 946334 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1534837304 proquest_miscellaneous_1022839890 proquest_journals_1517117747 pubmed_primary_22231486 pascalfrancis_primary_26177047 crossref_citationtrail_10_1002_art_34376 crossref_primary_10_1002_art_34376 wiley_primary_10_1002_art_34376_ART34376 istex_primary_ark_67375_WNG_VW2ZXKC4_C |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2012 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 07 year: 2012 text: July 2012 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken , NJ – name: United States – name: Atlanta |
PublicationTitle | Arthritis & rheumatology (Hoboken, N.J.) |
PublicationTitleAlternate | Arthritis & Rheumatism |
PublicationYear | 2012 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley – name: Wiley Subscription Services, Inc |
References | Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-61. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-8. Fukasawa C, Kawaguchi Y, Harigai M, Sugiura T, Takagi K, Kawamoto M, et al. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts. Eur J Immunol 2003; 33: 2792-800. Sakkas LI, Xu B, Arlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002; 168: 3649-59. Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91. Komura K, Fujimoto M, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, et al. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Ann Rheum Dis 2008; 67: 867-72. Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315: 1141-3. Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372-3. Singer-Sam J, Riggs AD. X chromosome inactivation and DNA methylation. EXS 1993; 64: 358-84. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6. Chang SC, Tucker T, Thorogood NP, Brown CJ. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852-66. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11. Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 2011; 10: 641-6. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-80. Richardson B. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: 2401-5. Chow JC, Brown CJ. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell Mol Life Sci 2003; 60: 2586-603. Robertson KD. DNA methylation and chromatin: unraveling the tangled web. Oncogene 2002; 21: 5361-79. Valentini G, Romano MF, Naclerio C, Bisogni R, Lamberti A, Turco MC, et al. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmun 2000; 15: 61-6. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs. J Immunol 2005; 174: 6212-9. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922. Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003; 27: 185-202. Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008; 38: 132-60. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-67. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-74. Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32: 202-11. Kawai M, Masuda A, Kuwana M. A CD40-CD154 interaction in tissue fibrosis. Arthritis Rheum 2008; 58: 3562-73. Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, et al. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 2011; 10: 624-30. Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004; 31: 514-9. Miga A, Masters S, Gonzalez M, Noelle RJ. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000; 29: 111-4. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19. 2010; 34 2000; 29 2005; 174 2002; 132 2006; 11 2008; 38 1993; 64 2008; 58 2011; 10 2011; 32 1961; 190 2001; 44 2003; 33 2009; 33 2004; 31 2007; 179 2007; 315 2000; 15 2002; 168 2004; 37 2002; 46 2002; 21 2004; 172 1994; 12 2008; 67 2003; 27 2001; 2 2003; 60 2009; 38 Singer‐Sam J (e_1_2_6_13_2) 1993; 64 e_1_2_6_31_2 e_1_2_6_30_2 e_1_2_6_18_2 e_1_2_6_19_2 Komura K (e_1_2_6_10_2) 2004; 31 e_1_2_6_12_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – reference: Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91. – reference: Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 2011; 10: 641-6. – reference: Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32: 202-11. – reference: Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315: 1141-3. – reference: Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, et al. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 2011; 10: 624-30. – reference: Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372-3. – reference: Robertson KD. DNA methylation and chromatin: unraveling the tangled web. Oncogene 2002; 21: 5361-79. – reference: Chang SC, Tucker T, Thorogood NP, Brown CJ. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852-66. – reference: Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-67. – reference: Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-74. – reference: Miga A, Masters S, Gonzalez M, Noelle RJ. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000; 29: 111-4. – reference: Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19. – reference: Valentini G, Romano MF, Naclerio C, Bisogni R, Lamberti A, Turco MC, et al. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmun 2000; 15: 61-6. – reference: Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs. J Immunol 2005; 174: 6212-9. – reference: Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004; 31: 514-9. – reference: Komura K, Fujimoto M, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, et al. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Ann Rheum Dis 2008; 67: 867-72. – reference: Kawai M, Masuda A, Kuwana M. A CD40-CD154 interaction in tissue fibrosis. Arthritis Rheum 2008; 58: 3562-73. – reference: Chow JC, Brown CJ. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell Mol Life Sci 2003; 60: 2586-603. – reference: Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6. – reference: Singer-Sam J, Riggs AD. X chromosome inactivation and DNA methylation. EXS 1993; 64: 358-84. – reference: Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008; 38: 132-60. – reference: Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003; 27: 185-202. – reference: Sakkas LI, Xu B, Arlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002; 168: 3649-59. – reference: Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-61. – reference: Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11. – reference: Fukasawa C, Kawaguchi Y, Harigai M, Sugiura T, Takagi K, Kawamoto M, et al. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts. Eur J Immunol 2003; 33: 2792-800. – reference: Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922. – reference: Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-8. – reference: Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-80. – reference: Richardson B. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: 2401-5. – volume: 38 start-page: 132 year: 2008 end-page: 60 article-title: The immunobiology of systemic sclerosis publication-title: Semin Arthritis Rheum – volume: 12 start-page: 881 year: 1994 end-page: 922 article-title: The CD40 antigen and its ligand publication-title: Annu Rev Immunol – volume: 64 start-page: 358 year: 1993 end-page: 84 article-title: X chromosome inactivation and DNA methylation publication-title: EXS – volume: 33 start-page: 3 year: 2009 end-page: 11 article-title: The genetics and epigenetics of autoimmune diseases publication-title: J Autoimmun – volume: 10 start-page: 641 year: 2011 end-page: 6 article-title: Cellular players in angiogenesis during the course of systemic sclerosis publication-title: Autoimmun Rev – volume: 132 start-page: 2401 year: 2002 end-page: 5 article-title: Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer publication-title: J Nutr – volume: 179 start-page: 6352 year: 2007 end-page: 8 article-title: Demethylation of CD40LG on the inactive X in T cells from women with lupus publication-title: J Immunol – volume: 32 start-page: 202 year: 2011 end-page: 11 article-title: Innate control of B cell responses publication-title: Trends Immunol – volume: 60 start-page: 2586 year: 2003 end-page: 603 article-title: Forming facultative heterochromatin: silencing of an X chromosome in mammalian females publication-title: Cell Mol Life Sci – volume: 190 start-page: 372 year: 1961 end-page: 3 article-title: Gene action in the X‐chromosome of the mouse (mus musculus L.) publication-title: Nature – volume: 33 start-page: 2792 year: 2003 end-page: 800 article-title: Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts publication-title: Eur J Immunol – volume: 34 start-page: J207 year: 2010 end-page: 19 article-title: Epigenetics and autoimmunity publication-title: J Autoimmun – volume: 172 start-page: 3652 year: 2004 end-page: 61 article-title: Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells publication-title: J Immunol – volume: 315 start-page: 1141 year: 2007 end-page: 3 article-title: Gene body‐specific methylation on the active X chromosome publication-title: Science – volume: 27 start-page: 185 year: 2003 end-page: 202 article-title: CD154 transcriptional regulation in primary human CD4 T cells publication-title: Immunol Res – volume: 29 start-page: 111 year: 2000 end-page: 4 article-title: The role of CD40‐CD154 interactions in the regulation of cell mediated immunity publication-title: Immunol Invest – volume: 44 start-page: 735 year: 2001 end-page: 6 article-title: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma publication-title: Arthritis Rheum – volume: 10 start-page: 624 year: 2011 end-page: 30 article-title: B cells in systemic sclerosis: a possible target for therapy publication-title: Autoimmun Rev – volume: 37 start-page: 457 year: 2004 end-page: 67 article-title: The role of CD40‐CD154 interactions in autoimmunity and the benefit of disrupting this pathway publication-title: Autoimmunity – volume: 168 start-page: 3649 year: 2002 end-page: 59 article-title: Oligoclonal T cell expansion in the skin of patients with systemic sclerosis publication-title: J Immunol – volume: 38 start-page: 369 year: 2009 end-page: 74 article-title: Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis publication-title: Scand J Rheumatol – volume: 21 start-page: 5361 year: 2002 end-page: 79 article-title: DNA methylation and chromatin: unraveling the tangled web publication-title: Oncogene – volume: 58 start-page: 3562 year: 2008 end-page: 73 article-title: A CD40–CD154 interaction in tissue fibrosis publication-title: Arthritis Rheum – volume: 67 start-page: 867 year: 2008 end-page: 72 article-title: Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight‐skin mouse publication-title: Ann Rheum Dis – volume: 31 start-page: 514 year: 2004 end-page: 9 article-title: Elevated circulating CD40L concentrations in patients with systemic sclerosis publication-title: J Rheumatol – volume: 15 start-page: 61 year: 2000 end-page: 6 article-title: Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients publication-title: J Autoimmun – volume: 174 start-page: 6212 year: 2005 end-page: 9 article-title: Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs publication-title: J Immunol – volume: 2 start-page: 777 year: 2001 end-page: 80 article-title: Sex differences in autoimmune disease publication-title: Nat Immunol – volume: 11 start-page: 852 year: 2006 end-page: 66 article-title: Mechanisms of X‐chromosome inactivation publication-title: Front Biosci – volume: 46 start-page: 1282 year: 2002 end-page: 91 article-title: Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus publication-title: Arthritis Rheum – ident: e_1_2_6_3_2 doi: 10.1038/ni0901-777 – ident: e_1_2_6_24_2 doi: 10.1093/jn/132.8.2401S – ident: e_1_2_6_21_2 doi: 10.1002/eji.200324088 – ident: e_1_2_6_28_2 doi: 10.4049/jimmunol.174.10.6212 – ident: e_1_2_6_25_2 doi: 10.1016/j.jaut.2009.03.007 – ident: e_1_2_6_2_2 doi: 10.1016/j.autrev.2011.04.013 – ident: e_1_2_6_5_2 doi: 10.4049/jimmunol.168.7.3649 – ident: e_1_2_6_18_2 doi: 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F – ident: e_1_2_6_11_2 doi: 10.1136/ard.2007.073387 – ident: e_1_2_6_22_2 doi: 10.1002/art.23994 – ident: e_1_2_6_29_2 doi: 10.4049/jimmunol.172.6.3652 – ident: e_1_2_6_14_2 doi: 10.2741/1842 – volume: 64 start-page: 358 year: 1993 ident: e_1_2_6_13_2 article-title: X chromosome inactivation and DNA methylation publication-title: EXS – ident: e_1_2_6_30_2 doi: 10.1080/03009740902758875 – ident: e_1_2_6_26_2 doi: 10.1016/j.jaut.2009.12.006 – ident: e_1_2_6_27_2 doi: 10.1002/art.10234 – ident: e_1_2_6_16_2 doi: 10.1038/sj.onc.1205609 – ident: e_1_2_6_15_2 doi: 10.1126/science.1136352 – ident: e_1_2_6_23_2 doi: 10.3109/08820130009062292 – volume: 31 start-page: 514 year: 2004 ident: e_1_2_6_10_2 article-title: Elevated circulating CD40L concentrations in patients with systemic sclerosis publication-title: J Rheumatol – ident: e_1_2_6_4_2 doi: 10.1016/j.semarthrit.2007.10.010 – ident: e_1_2_6_17_2 doi: 10.4049/jimmunol.179.9.6352 – ident: e_1_2_6_7_2 doi: 10.1016/j.it.2011.02.004 – ident: e_1_2_6_20_2 doi: 10.1080/08916930400002386 – ident: e_1_2_6_6_2 doi: 10.1016/j.autrev.2011.04.016 – ident: e_1_2_6_31_2 doi: 10.1007/s00018-003-3121-9 – ident: e_1_2_6_8_2 doi: 10.1146/annurev.iy.12.040194.004313 – ident: e_1_2_6_9_2 doi: 10.1006/jaut.2000.0387 – ident: e_1_2_6_12_2 doi: 10.1038/190372a0 – ident: e_1_2_6_19_2 doi: 10.1385/IR:27:2-3:185 |
SSID | ssj0002353 ssj0000970605 |
Score | 2.4226353 |
Snippet | Objective
Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be... Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the... Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2338 |
SubjectTerms | Adult Biological and medical sciences CD4-Positive T-Lymphocytes - immunology CD40 Ligand - genetics Chromosomes Deoxyribonucleic acid Disease Susceptibility Diseases of the osteoarticular system DNA DNA methylation DNA Methylation - genetics DNA Methylation - immunology Female Gene Expression Regulation Humans Lymphocytes Male Medical research Medical sciences Middle Aged Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Scleroderma, Systemic - genetics Scleroderma, Systemic - immunology Sex Factors |
Title | DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility |
URI | https://api.istex.fr/ark:/67375/WNG-VW2ZXKC4-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.34376 https://www.ncbi.nlm.nih.gov/pubmed/22231486 https://www.proquest.com/docview/1517117747 https://www.proquest.com/docview/1022839890 https://www.proquest.com/docview/1534837304 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLamISFeuF8CozIIoUkoXRo7F8NT1TEGgz6gjVUIybITW6pW0mpppY0X_jrn2EmqooEQb5FyHMUn5zv-bJ98JuQFL0Wei5yFNrc25ADtUGvGQpZHhVAJ45mv8h2nhyf8wySZbJE37b8wXh-iW3BDZLh8jQBXut5bi4aCZ_uMAz4g_2KtFhKiz2vpqJg1CpS48p-IQasqFMV7XcuNsegauvUCayNVDe6x_lyLq4jnJo91A9HBLfKt7YKvPznrr5a6X_z4Td3xP_t4m9xsCCod-oi6Q7ZMdZdc_9Rswd8jP_fHQ1oaPHn60tfR0bmlo30efaTTCi9e0WOK-wE1xX9XqNN4oLjeS71s9LSgNTwaXDKtX9MhXcwRlzNDzcVipvzqJAUuTa35DsMXrVe1q71xZbyX98nJwdvj0WHYnOIQFjzhaVgCR4m15joRNiph7p6n2lrNVJYmJo5tkrJBKVQcKWCiQqmBYSmwzsREg8IIJtgDsl3NK_OI0KJwhDNTJcyCYOgVpoSEZYVV0MZkeUB22-8pi0biHE_amEkvzhxLcKh0Dg3I88504XU9rjJ66YKis1DnZ1gIlyXydPxOfjmNv06ORlyOAtLbiJquAerdZxHPArLThpFskkQtgWxluGeOt591twHe-I1UZeYrsHH6RCIX0V9sAFI5g1TNA_LQh-j6BYD-wYwXurLrAu3PnZUwgXIXj__d9Am5AQSyKV_eIdvL85V5CiRtqXuAxvdHPYfJX7qnNx0 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFLWmTQJexjcExjAI0CSULo2dDyPxULWMjnZ9QB2reDFOYkvVurRaWrHywh_ir_CfuLaTVEUD8bIH3iLlpop9fa_PdU_ORegFzVgcs5i4KlbKpRDabpIQ4pLYS5kICI0sy3cQdo_ph1Ew2kA_qm9hrD5EfeCmI8Pkax3g-kB6f6UaClPbIBQCpKRU9uTyKxRsxdvDDnj3pe8fvBu2u27ZU8BNaUBDN4Md008SmgRMeRlUknGYKJUQEYWB9H0VhKSZMeF7AnARE6IpSQgYKJBeM5WMaOklSPhbuoO4VurvfFyJVYFV2beNuiRgzUrHyPP361dd2_22tCMvNBtTFOAQZTtpXAZ115Gz2foObqKf1aRZxstpYzFPGum33_Qk_5dZvYW2SwyOWzZobqMNmd9B145KlsFd9L0zaOFM6ubaS0sVxFOF2x3q9fE41xev8RDrvzwKrD_PwUbGAusjbWyVsccpLuCnwQfj4g1u4dlUp56JxPJiNhH2ABZDuYCVPIMdGheLwtCLDFN5eQ8dX8nw76PNfJrLhwinqcHUkcig0AN0wWQGOVkxJeAZGcUO2qsWEE9LFXfdTGTCrf60z8GB3DjQQc9r05mVLrnM6JVZhbWFOD_VXL8o4CeD9_zTif951GtT3nbQ7toyrR_Qkv6RRyMH7VTrlpd5sOCAJyNNC9C3n9W3IYNpH4lcThdgYySYWMy8v9hA1ogJ7EbUQQ9sTKxeABAuFPUwlD2zsv88WA41orl49O-mT9H17vCoz_uHg95jdAPwcsnW3kGb8_OFfAKYdJ7smlSA0ZerjpJfhC-Tag |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFLWmTZp4YXyTMYZBgCahdGnsfBiJh6qhbHRUCG2s4sU4iS1VK2m1tGLlhR_EX-FHcW0nqYoG4mUPvEXKTRX7-l6f656ci9BTmrM4ZjFxVayUSyG03TQlxCWxlzEREBpZlu8gPDihb4fBcA39qL-FsfoQzYGbjgyTr3WAT3O1vxQNhZltEQrxUTEq-3LxFeq18tVhAs595vu918fdA7dqKeBmNKChm8OG6acpTQOmvBwKyThMlUqJiMJA-r4KQtLOmfA9AbCICdGWJAQIFEivnUlGtPIS5PsNGnpM94lIPiy1qsCqattGXRKwdi1j5Pn7zauubH4b2o8XmowpSvCHso00LkO6q8DZ7Hy9LfSznjNLeDlrzWdpK_v2m5zkfzKpN9D1CoHjjg2Zm2hNFrfQ5ruKY3AbfU8GHZxL3Vp7YYmCeKJwN6HeER4V-uIFPsb6D48S649zsBGxwPpAG1td7FGGS_hpcMGofIk7eDrRiWcssbyYjoU9fsVQLGAlv8D-jMt5achFhqe8uINOrmT4d9F6MSnkfYSzzCDqSORQ5gG2YDKHjKyYEvCMjGIH7dXrh2eVhrtuJTLmVn3a5-BAbhzooCeN6dQKl1xm9NwswsZCnJ9ppl8U8NPBG_7x1P807Hcp7zpod2WVNg9oQf_Io5GDduply6ssWHJAk5EmBejbj5vbkL-0j0QhJ3OwMQJMLGbeX2wgZ8QE9iLqoHs2JJYvAPgWSnoYyp5Z2H8eLIcK0Vxs_7vpI7T5Punxo8NB_wG6BmC5omrvoPXZ-Vw-BEA6S3dNIsDo81UHyS8kUpIZ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DNA+demethylation+of+CD40L+in+CD4%2B+T+cells+from+women+with+systemic+sclerosis%3A+A+possible+explanation+for+female+susceptibility&rft.jtitle=Arthritis+and+rheumatism&rft.au=Lian%2C+XiaoRi&rft.au=Xiao%2C+Rong&rft.au=Hu%2C+Xinhong&rft.au=Kanekura%2C+Takuro&rft.date=2012-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0004-3591&rft.eissn=1529-0131&rft.volume=64&rft.issue=7&rft.spage=2338&rft.epage=2345&rft_id=info:doi/10.1002%2Fart.34376&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_VW2ZXKC4_C |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon |